Skip to main content
. 2020 Apr 21;3(4):e203144. doi: 10.1001/jamanetworkopen.2020.3144

Table 2. Key Appropriate Use Variables.

Variable No. (%) P value
Total (N = 2611) Appropriate (n = 778) Rarely appropriate (n = 272) May be appropriate (n = 1561)
Chest pain or dyspnea 2515 (96.3) 776 (99.7) 216 (79.4) 1523 (97.6) <.001
Noninvasive evaluation results
Low risk 378 (18.1) 15 (1.9) 220 (89.1) 143 (13.5) <.001
Intermediate risk 1049 (50.3) 239 (30.7) 26 (10.5) 784 (73.8)
High risk 639 (30.6) 524 (67.4) 0 115 (10.8)
None performed 526 (20.9) 0 25 (9.2) 501 (32.1)
Antianginals, No.
0 621 (23.8) 96 (12.3) 100 (36.8) 425 (27.2) <.001
1 1305 (50.0) 260 (33.4) 167 (61.4) 878 (56.2)
2 645 (24.7) 400 (51.4) 5 (1.8) 240 (15.4)
3 40 (1.5) 22 (2.8) 0 18 (1.2)
Coronary artery stenoses
1 1560 (59.7) 404 (51.9) 185 (68.0) 971 (62.2) <.001
2 702 (26.9) 215 (27.6) 76 (27.9) 411 (26.3)
3 or left main 332 (12.7) 154 (19.8) 11 (4.0) 167 (10.7)